Cosmo Pharma: Shares jump on EU recommendation of colonoscopy drug

Cosmo NV

26/06/2020 08:36

** Shares in Cosmo Pharmaceuticals rise 4.8% after the Swiss
company gets a positive opinion for its drug for visualizing
colorectal lesions during colonoscopies  urn:newsml:reuters.com:*:nFWN2E211S
    ** The European Medicines Agency's Committee for Medicinal
Products for Human Use has issued a recommendation to approve
Cosmo's Methylene Blue MMX, the company says
    ** The final decision on the authorisation of Methylene Blue
MMX for marketing in Europe is expected in the next couple of
months, Cosmo says

 ((zuzanna.szymanska@tr.com))